Use of biphasic ınsulin aspart 30 in type 2 diabetes treatment: expert panelrecommendations
Yükleniyor...
Dosyalar
Tarih
2018
Yazarlar
Dergi Başlığı
Dergi ISSN
Cilt Başlığı
Yayıncı
Galenos yayıncılık, erkan mor, molla guranı cad 21-1, fındıkzade, ıstanbul 34093, turkey
Erişim Hakkı
info:eu-repo/semantics/openAccess
Özet
The goals of Type 2 diabetes treatment are to eliminate the hyperglycemia resulting from insulin insufficiency and/or insulin resistance, delay beta cell damage/depletion, and prevent other metabolic co-morbidities and complications. In the current treatment algorithms, lifestyle changes (medical nutrition therapy, physical exercise) and oral anti-diabetics are followed by insulin therapy, which is considered a replacement therapy for Type 2 diabetes. Pre-mixed insulin preparations, which are an option for patients with poor blood glucose level control under oral anti-diabetics treatment, have been developed to meet both basal and prandial insulin needs by simulating the physiological changes in insulin levels. The consensus on the necessity of individualizing insulin therapy requires physicians to have a detailed knowledge of the various uses of insulin. Therefore, this comprehensive consensus statement has been prepared by a panel of expert endocrinologists from different regions of Turkey to help physicians use biphasic insulin aspart 30 in suitable patients at the right time. In this statement, expert panel opinions on (a) Recommendations for the appropriate initiation, titration, and intensification of insulin treatment, and (b) The treatment algorithms in initiation, titration, and intensification of biphasic insulin aspart 30 treatment and special conditions specific to changing treatment regimen are presented.
Açıklama
Anahtar Kelimeler
Postprandıal Plasma-Glucose, Pancreatıc-Cancer, Glycemıc Control, Clınıcal Endocrınologısts, Cardıovascular Events, Amerıcan Assocıatıon, Premıxed Formulatıon, Independent Rısk, Humalog Mıx25, Blood-Glucose
Kaynak
Turkısh journal of endocrınology and metabolısm
WoS Q Değeri
Scopus Q Değeri
Cilt
22
Sayı
3
Künye
Şahin, İ. (2018). Use of biphasic ınsulin aspart 30 in type 2 diabetes treatment: expert panelrecommendations. Cilt:22 Sayı:3, 183-197 ss.
